Zoetis Inc. (NYSE: ZTS) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Steve Frank -- Vice President of Investor Relations KristIn Peck -- Chief
Zoetis Inc. (ZTS) Q2 2020 Earnings Call Transcript
Categories
Health Care
Karyopharm Therapeutics Inc. (KPTI) Q2 2020 Earnings Call Transcript
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Ian Karp -- Vice President, Investor and Public Relations
Mylan N.V. (MYL) Q2 2020 Earnings Call Transcript
Mylan N.V. (NASDAQ: MYL) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Melissa Trombetta -- Head of Global Investor Relations Heather Bresch -- Chief
Metlife Inc. (MET) Q2 2020 Earnings Conference Call Transcript
Metlife Inc. (NYSE: MET) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: John Hall -- Head of Investor Relations Michel A. Khalaf -- President
Highlights of Bristol-Myers Squibb Company (NYSE: BMY) Q2 2020 Earnings
https://www.youtube.com/watch?v=dYv_jstT8BY&t=18s Pharmaceutical firm Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2020 financial results on Thursday morning. The results were better than analysts’
Amarin Corporation plc (AMRN) Q2 2020 Earnings Call Transcript
Amarin Corporation plc (NASDAQ: AMRN) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director of Investor Relations John
Humana Inc (HUM) Q2 2020 Earnings Call Transcript
Humana Inc (NYSE: HUM) Q2 2020 earnings call dated August 5, 2020 Corporate Participants: Amy Smith -- Vice President of Investor Relations Bruce Broussard -- President
Moderna, Inc. (MRNA) Q2 2020 Earnings Conference Call Transcript
Moderna Inc. (NASDAQ: MRNA) Q2 2020 earnings call dated Aug. 05, 2020 Corporate Participants: Lavina Talukdar -- Head of Investor Relations Stephane Bancel -- Chief Executive
CVS Health Corp. (CVS) Q2 2020 Earnings Call Transcript
CVS Health Corp. (NYSE: CVS) Q2 2020 earrings call dated Aug. 05, 2020 Corporate Participants: Valerie C. Haertel -- Senior Vice President of Investor
Teva Pharmaceuticals (TEVA) Q2 2020 earnings: Reaffirms FY20 outlook
Teva Pharmaceuticals (NYSE: TEVA) beat Q2 earnings estimates, but fell short of Street's revenue targets. The drug manufacturer reported adjusted EPS of
Moderna impresses on the financial side as well in Q2
Moderna, Inc., (Nasdaq: MRNA), a prime contender in Covid-19 vaccine research, on Wednesday, reported second-quarter financial results that smashed past analysts’ estimates.
Amarin (AMRN) Q2 2020 earnings call: Focus was mainly on VASCEPA litigation
Amarin (NASDAQ: AMRN) reported second quarter 2020 results yesterday. During the earnings conference call, the management and the analysts discussed mainly the
Key highlights from CVS Health (CVS) Q2 2020 earnings results
CVS Health Corporation (NYSE: CVS) reported second quarter 2020 earnings results today. Total revenues increased 3% to $65.3 billion, driven by growth
Amarin (AMRN) maintains revenue growth despite COVID-19 headwinds
Amarin Corporation plc (NASDAQ:AMRN) reported second quarter 2020 earnings results today. The company reported a 34% growth in total revenue to $135.3
McKesson Corp. (MCK) Q1 2021 Earnings Call Transcript
McKesson Corp. (NYSE: MCK) Q1 2021 earnings call dated Aug. 03, 2020 Corporate Participants: Holly Weiss -- Senior Vice President of Investor Relations Brian
Strong performance of oncology products bode well for AbbVie (ABBV) going forward
AbbVie Inc. (NYSE: ABBV) reported better-than-expected results for the second quarter of 2020 on Friday. The company reported a 26% increase in
Molina Healthcare Inc (MOH) Q2 2020 Earnings Call Transcript
Molina Healthcare Inc (NYSE: MOH) Q2 2020 earnings call dated July 31, 2020 Corporate Participants: Julie Trudell -- Senior Vice President of Investor Relations
Immunogen Inc. (IMGN) Q2 2020 Earnings Call Transcript
Immunogen Inc (NASDAQ: IMGN) Q2 2020 earnings call dated July 31, 2020 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor
ImmunoGen (IMGN) Earnings: 2Q20 Key Numbers
ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today. Revenues were $15 million, compared to $15.5 million in the prior-year period. Net loss
Merck & Co., Inc. (MRK) Q2 2020 Earnings Call Transcript
Merck & Co., Inc. (NYSE: MRK) Q2 2020 earnings call dated July 31, 2020 https://youtu.be/kKm2dyqbeW0 Corporate Participants: Peter Dannenbaum -- Vice President of Investor
Eli Lilly & Co. (LLY) Q2 2020 Earnings Call Transcript
Eli Lilly & Co. (NYSE: LLY) Q2 2020 earnings call dated July 30, 2020 https://www.youtube.com/watch?v=d4-cSFo067A Presentation: Operator Ladies and gentlemen, thank you